Wrong IP. Access was denied.
SVATOŠ ALEŠ; KALINOVÁ BLANKA; HOSKOVEC MICHAL; KINDL JIŘÍ; HRDÝ IVAN :
(E8,Z10)-TETRADECA-8,10-DIENAL, THE METHOD OF ITS PREPARATION AND ITS USE AS SEXUAL ATTRACTANT FOR LEAFMINER MOTHS
Abstract for EP 1192117
The subject of the invention are isomerically pure tetradeca-8,10-dienals, the synthetic preparation thereof and their use as sex attractants for leafminers of the genus Gracillariidae (Lepidotpera, Insecta), in particular the means of preparation of the (E8,Z10)-tetradeca-8,10-dienal and its utilization as a sex attractant for horse chestnut leafminer. This compound is directly, in a solution or in a mixture with additional compounds, or in the form of its pro-pheromone derivatives, applied on an appropriate support and then used in diverse types of traps.
http://v3.espacenet.com/publicationDetails/originalDocument?FT=D&date=20040901&DB=EPODOC&locale=en_EP&CC=EP&NR=1192117B1&KC=B1
KOHOUT LADISLAV; KASAL ALEXANDER; CHODOUNSKÁ HANA; SLAVÍKOVÁ BARBORA; HNILIČKOVÁ JAROSLAVA:
Use of 2alpha, 3alpha, 17beta-trihydro-5alpha androstan-6-one for influencing stress in plants
Abstract of WO 03003834
In the present invention, there is disclosed the use of 2{alpha}, 3{alpha},17{beta}trihydroxy-5{alpha}-androstan-6-one as an active component for controlling stress in plants in the form of am application solution. This compound is very convenient active ingredient for use as plant growth regulator, i.e. for influencing of different plant growth stages including removing of stress effects.
HOCEK MICHAL; ČAPEK PETR:
(PURIN-6-YL) AMINO ACID AND PRODUCTION METHOD THEREOF
Abstract of WO 2004094426
The invention provides a synthetic method of (purin-6-yl)amino acids which are useful as medicaments of anticancer, anti-virus agents and so on or their intermediates. Above mentined acids can be produced easily according to the method of the present invention.
KONVALINKA JAN [CZ]; UHLÍKOVA TAŤÁNA [CZ]; DANTUMA NICOLAAS PIETER [SE]; MASUCCI MARIA [SE]; LINDSTEN KRISTINA [SE]
ASSAYS FOR PROTEASE INHIBITORS, METHODS AND MEANS
Abstract of WO 03012131
A fusion protein is provided in cells in culture that comprises (i) an autoproteolytic precursor of a cytotoxic protease and (ii) a reporter protein, which reporter protein provides a quantitative signal indicative of amount of reporter protein present within the cells, allowing for assays to identify inhibitors of the protease and potential therapeutics useful in targeting pathogens, especially viruses such as HIV.
HOLÝ ANTONÍN; OTMAR MIROSLAV; PÍSKALA ALOIS; VOTRUBA IVAN; KOVAŘÍK ALEŠ; FOJTOVÁ MILOSLAVA; BARTOVÁ EVA
1-(2-DEOXY-ALPHA-D-ERYTHRO-PENTOFURANOSYL)-5-AZACYTOSINE FOR USE AS DRUG
Abstract of WO 2008083634 (A1)
The invention relates to 1-(2-deoxy-alpha-D-erythro-pentofuranosyl)-5-azacytosine of formula (I) for use as a hypomethylating drug applicable for epigenetic therapy of cancer and other epigenetically determined diseases and further includes the use of the compound of formula (I) for manufacturing of a pharmaceutical composition.
ČEŘOVSKÝ VÁCLAV; SLANINOVÁ JIŘINA; FUČÍK VLADIMÍR; BEDNÁŘOVÁ LUCIE; VOTRUBA IVAN; BOROVIČKOVÁ LENKA; TURÁNEK JAROSLAV
Novel synthetic peptides and use thereof
Abstract of CZ 301595 (B6)
In the present invention, there are described novel synthetic analogs of melectin peptide being originally isolated from poison sac of solitary bees Melecta albifrons, prepared by modification of its structural units by a coded amino acid, a non-coded amino acid or by an amino acid in D-configuration. These substances are suitable for preparing a medicament intended for the treatment of microbial, viral, parasitic and fungal diseases as well as for the treatment of cancers.